CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS
NCT06252402
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
HIV-1
Interventions
BIOLOGICAL:
CMV/HIV-CAR T Cells
Sponsor
City of Hope Medical Center